Eterna Therapeutics
ERNA
6 hedge funds and large institutions have $1.42M invested in Eterna Therapeutics in 2018 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.
33% less funds holding
Funds holding: 9 → 6 (-3)
71% less capital invested
Capital invested by funds: $4.94M → $1.42M (-$3.52M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$47.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$1.27M |
| 2 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$320K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$110K |
| 4 |
Barclays
London,
United Kingdom
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NSIM
1
North Star Investment Management
Chicago,
Illinois
| $585K | – | – | – |
|
|
BA
2
Bard Associates
Chicago,
Illinois
| $567K | – | – | – |
|
3
Renaissance Technologies
New York
| $89K | – | – | – |
|
|
4
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $59K | +$47.4K | +1 | +100% |
|
5
Geode Capital Management
Boston,
Massachusetts
| $41K | – | – | – |
|
|
CA
6
Callahan Advisors
Houston,
Texas
| $37K | – | – | – |
|
7
Vanguard Group
Malvern,
Pennsylvania
| $32K | – | – | – |
|
8
BlackRock
New York
| $6K | – | – | – |
|
9
UBS Group
Zurich,
Switzerland
| $6K | – | – | – |
|
10
Bank of America
Charlotte,
North Carolina
| $2K | – | – | – |
|
|
AIC
11
AWM Investment Company
New York
| – | -$1.27M | -19 | Closed |
|
|
EAM
12
Eagle Asset Management
St Petersburg,
Florida
| – | -$320K | -5 | Closed |
|
|
13
Citadel Advisors
Miami,
Florida
| – | -$110K | -2 | Closed |
|
|
14
Barclays
London,
United Kingdom
| – | -$1K | – | – |
|
ERNA Hedge Fund Activity: Q4 2018 in Review
6 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q4 2018, worth a combined $1.42M — down 71% from $4.94M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ERNA and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was PNC Financial Services Group, adding an estimated $47.4K. The largest seller was AWM Investment Company, exiting entirely with an estimated $1.27M sold.
- 6 institutional investors held Eterna Therapeutics (ERNA) as of Q4 2018, down from 9 in Q3 2018.
- Funds reported $1.42M of Eterna Therapeutics stock for Q4 2018, down 71% quarter-over-quarter.
- 0 funds opened new Eterna Therapeutics positions in Q4 2018 and 3 closed out, a net change of -3 holders.
- The largest Eterna Therapeutics buyer in Q4 2018 was PNC Financial Services Group, an estimated $47.4K added.
- The largest Eterna Therapeutics seller in Q4 2018 was AWM Investment Company, an estimated $1.27M sold.
Based on aggregated 13F filings for Q4 2018.